SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Stock Picking for Charity - 2005

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (195)9/27/2005 10:29:50 AM
From: Icebrg  Read Replies (1) of 322
 
Four directors including Spinelli and the Chairman wanted a change on the CEO position. They left when they couldn't have their way.

If today's news really represent a chance for the revival of Xyotax, I don't think they would have acted in such a way (i.e. asking for Bianco's removal).

Comparing the results for men and women doesn't make much sense to me. I believe FDA would like to see that the drug does better or at least as well as current drugs on the market. Not that there are differences in treatment effects between men and women.

I had loaded up my portfolio with 20.000 USD worth of CTIC. I trusted, that Spinelli had done a proper evaluation of CTIC and Xyotax before he agreed to the merger.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext